Alendronate for Osteoporosis; Exercise Training in Patients with Chronic Heart Failure; Cardiovascular Prognosis of Masked Hypertension; Short-term Intensive Insulin Therapy in Newly Diagnosed DM2; Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus; Treatment of Parkinsons Disease with Pergolide and Relation to Restrictive Valvular Heart Disease.
Alendronate for Osteoporosis; Exercise Training in Patients with Chronic Heart Failure; Cardiovascular Prognosis of Masked Hypertension; Short-term Intensive Insulin Therapy in Newly Diagnosed DM2; Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus; Treatment of Parkinsons Disease with Pergolide and Relation to Restrictive Valvular Heart Disease.
Clinical Briefs in Primary Care
July 1, 2004